Logo image of QDEL

QUIDELORTHO CORP (QDEL) Stock Price, Forecast & Analysis

USA - NASDAQ:QDEL - US2197981051 - Common Stock

26.99 USD
+0.18 (+0.67%)
Last: 10/31/2025, 4:30:01 PM
26.99 USD
0 (0%)
After Hours: 10/31/2025, 4:30:01 PM

QDEL Key Statistics, Chart & Performance

Key Statistics
Market Cap1.83B
Revenue(TTM)2.74B
Net Income(TTM)-466400000
Shares67.90M
Float66.80M
52 Week High49.45
52 Week Low22.05
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)2.34
PE11.53
Fwd PE8.96
Earnings (Next)11-06 2025-11-06/amc
IPO1991-02-01
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


QDEL short term performance overview.The bars show the price performance of QDEL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 10 -10 15

QDEL long term performance overview.The bars show the price performance of QDEL in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of QDEL is 26.99 USD. In the past month the price decreased by -9.97%. In the past year, price decreased by -30.97%.

QUIDELORTHO CORP / QDEL Daily stock chart

QDEL Latest News, Press Relases and Analysis

QDEL Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 24.77 215.16B
ISRG INTUITIVE SURGICAL INC 62.05 191.53B
BSX BOSTON SCIENTIFIC CORP 34.14 149.24B
SYK STRYKER CORP 27.05 136.19B
MDT MEDTRONIC PLC 16.4 116.34B
BDX BECTON DICKINSON AND CO 12.52 51.22B
IDXX IDEXX LABORATORIES INC 52.42 50.36B
EW EDWARDS LIFESCIENCES CORP 32.08 48.41B
RMD RESMED INC 24.94 36.03B
GEHC GE HEALTHCARE TECHNOLOGY 16.33 34.22B
DXCM DEXCOM INC 31.3 22.83B
PHG KONINKLIJKE PHILIPS NVR- NY 16.46 26.31B

About QDEL

Company Profile

QDEL logo image QuidelOrtho Corp. operates as a vitro diagnostics company. The company is headquartered in San Diego, California and currently employs 6,600 full-time employees. The firm specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. The company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.

Company Info

QUIDELORTHO CORP

9975 Summers Ridge Road

San Diego CALIFORNIA 92121 US

CEO: Douglas C. Bryant

Employees: 6600

QDEL Company Website

QDEL Investor Relations

Phone: 18585521100

QUIDELORTHO CORP / QDEL FAQ

Can you describe the business of QUIDELORTHO CORP?

QuidelOrtho Corp. operates as a vitro diagnostics company. The company is headquartered in San Diego, California and currently employs 6,600 full-time employees. The firm specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. The company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.


What is the stock price of QUIDELORTHO CORP today?

The current stock price of QDEL is 26.99 USD. The price increased by 0.67% in the last trading session.


Does QDEL stock pay dividends?

QDEL does not pay a dividend.


How is the ChartMill rating for QUIDELORTHO CORP?

QDEL has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


How is the valuation of QUIDELORTHO CORP (QDEL) based on its PE ratio?

The PE ratio for QUIDELORTHO CORP (QDEL) is 11.53. This is based on the reported non-GAAP earnings per share of 2.34 and the current share price of 26.99 USD.


How many employees does QUIDELORTHO CORP have?

QUIDELORTHO CORP (QDEL) currently has 6600 employees.


When does QUIDELORTHO CORP (QDEL) report earnings?

QUIDELORTHO CORP (QDEL) will report earnings on 2025-11-06, after the market close.


QDEL Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to QDEL. When comparing the yearly performance of all stocks, QDEL is a bad performer in the overall market: 77.99% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

QDEL Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to QDEL. QDEL has a medium profitability rating, but doesn't score so well on its financial health evaluation.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

QDEL Financial Highlights

Over the last trailing twelve months QDEL reported a non-GAAP Earnings per Share(EPS) of 2.34. The EPS decreased by -4.1% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -7.31%
ROE -16.7%
Debt/Equity 0.74
Chartmill High Growth Momentum
EPS Q2Q%271.43%
Sales Q2Q%-3.63%
EPS 1Y (TTM)-4.1%
Revenue 1Y (TTM)-3.28%

QDEL Forecast & Estimates

14 analysts have analysed QDEL and the average price target is 42.16 USD. This implies a price increase of 56.21% is expected in the next year compared to the current price of 26.99.

For the next year, analysts expect an EPS growth of 22.53% and a revenue growth -2.61% for QDEL


Analysts
Analysts77.14
Price Target42.16 (56.21%)
EPS Next Y22.53%
Revenue Next Year-2.61%

QDEL Ownership

Ownership
Inst Owners117.77%
Ins Owners0.58%
Short Float %12.57%
Short Ratio6.84